Combination therapy for the inhibition of metastasis and tumorigenesis
US9877966B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Inventors
Key dates
| Filing date | Aug 10, 2016 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Aug 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5377
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides therapeutic compositions and methods for the inhibition of metastasis and for treatment of cancers in human and non-human mammals that are directed to the coformulation and/or coadministration of a dehydropyrimidine dehydrogenase inhibitor such as gimeracil and a pyrrolopyrimidine compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.